Pharming Group to participate in Canaccord Genuity 46th Annual Growth Conference
Pharming Group N.V., a global biopharmaceutical company listed on both Euronext Amsterdam and Nasdaq, announced its participation in the Canaccord Genuity 46th Annual Growth Conference in Boston on August 12-13, 2026. The company’s VP of Investor Relations and Capital Markets, Michael Levitan, will take part in a Fireside Chat Q&A session, offering…